Dr. Chris Bahl is the Head of Protein Design at the Institute for Protein Innovation in Boston, USA. His non-profit research group develops and combines computational protein design with automated high-throughput laboratory technologies to accelerate drug discovery and to engineer lead therapeutic molecules.
The Applied Photophysics Scientific Advisory Board is consisted with scientific leaders in both academia and industry.
John Gabrielson Ph.D.
Dr. John Gabrielson is the vice president of analytical sciences at KBI Biopharma. His main research interests are biophysics, particle characterization, analytical method capability, simulation & modelling. Dr. Gabrielson co-founded Elion Labs before it was acquired by KBI Biopharma.
Sandro Keller Ph.D.
Dr. Sandro Keller is a professor of molecular biophysics at Technische Universität Kaiserslautern, Germany. He will be a professor at University of Graz, Austria in September. His main research interests are membrane biophysics and membrane-mimetic systems (e.g., polymer-encapsulated nanodiscs).
Russ Middaugh Ph.D.
Dr. Russ Middaugh is a distinguished professor at the University of Kansas. His main research interests are the stability of proteins, DNA, macromolecular assemblies, virus-like particles, viruses, and bacterial cells for pharmaceutical use. He runs the macromolecule and vaccine stabilization center at the university.